Here's Why Momentum in Lantheus Holdings (LNTH) Should Keep goingZacks Investment Research • 03/29/22
Lantheus Announces Collaboration to Support Prostate Cancer Clinical DevelopmentGlobeNewsWire • 03/29/22
Is Lantheus Holdings (LNTH) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 03/25/22
Lantheus Holdings, Inc. (LNTH) CEO Mary Anne Heino on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/24/22
Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewsWire • 02/24/22
Lantheus Announces Presentation Featuring PYLARIFY® (Piflufolastat F18) at the 2022 ASCO GU MeetingGlobeNewsWire • 02/10/22
Lantheus Holdings to Host Fourth Quarter and Full Year 2021 Earnings Conference Call and Webcast on February 24, 2022 at 8:00 a.m. Eastern TimeGlobeNewsWire • 02/10/22
Lantheus Collaborates with The Prostate Cancer Clinical Trial Consortium (PCCTC) To Advance AI-Enabled Imaging Biomarkers in Prostate CancerGlobeNewsWire • 01/27/22
Lantheus Announces CMS Grants Transitional Pass-Through Payment for PYLARIFY® (piflufolastat F 18) Injection, Effective January 1, 2022GlobeNewsWire • 11/22/21
Lantheus Holdings Announces Presentations Featuring PYLARIFY® (Piflufolastat F 18), its PSMA-Targeted Prostate Cancer Imaging Agent, at Key Scientific MeetingsGlobeNewsWire • 11/17/21
Lantheus Holdings to Present at the 4th Annual Evercore ISI HealthCONx ConferenceGlobeNewsWire • 11/16/21
Lantheus Holdings, Inc. (LNTH) CEO Mary Anne Heino on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/06/21
Lantheus Holdings to Host Third Quarter 2021 Earnings Conference Call and Webcast on November 4, 2021 at 8:00 a.m. Eastern TimeGlobeNewsWire • 10/21/21
Lantheus and RefleXion Announce Development and Commercialization Collaboration with the Potential to Improve Future Prostate Cancer TreatmentGlobeNewsWire • 09/13/21